Identification of Virilizing Adrenal Tumors in Hirsute Women
- 13 October 1994
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 331 (15) , 968-973
- https://doi.org/10.1056/nejm199410133311502
Abstract
Hirsutism in women is usually caused by benign adrenal or ovarian disorders, but it can also be caused by adrenal carcinoma. The most effective way to identify such carcinomas is not known. We measured serum and urinary steroids before and after the administration of 3 mg of dexamethasone per day for five days in 14 hirsute women with histologically proved adrenal tumors (12 adrenal carcinomas and 2 adrenal adenomas) and in 73 women with hirsutism of non-neoplastic origin. All the women with adrenal tumors had elevated basal serum concentrations of testosterone or dehydroepiandrosterone sulfate, as compared with 36 of the 73 women with non-neoplastic hirsutism (sensitivity, 100 percent; 95 percent confidence interval, 77 to 100; specificity, 50 percent; 95 percent confidence interval, 38 to 62). After the administration of dexamethasone, serum dehydroepiandrosterone sulfate concentrations and urinary 17-ketosteroid excretion decreased to values similar to those in normal women in all the women with non-neoplastic hirsutism, but in none of the 12 with adrenal tumors who were tested. All the women who did not have adrenal tumors had serum cortisol concentrations below 3.3 μg per deciliter (90 nmol per liter) after dexamethasone administration, whereas in all 12 patients tested who had tumors the values were higher. The suppression of serum dehydroepiandrosterone sulfate and cortisol and urinary 17-ketosteroid excretion excluded the likelihood of adrenal tumors with a sensitivity of 100 percent (95 percent confidence interval, 74 to 100) and a specificity of 100 percent (95 percent confidence interval, 89 to 100). Among women with hirsutism, an adrenal tumor is unlikely if the patient has normal basal serum concentrations of testosterone and dehydroepiandrosterone sulfate. In women in whom these concentrations are elevated, a tumor is unlikely if the serum concentration of dehydroepiandrosterone sulfate and urinary 17-ketosteroid excretion are in the normal basal range and the serum cortisol concentration is less than 3.3 μg per deciliter after the administration of dexamethasone.Keywords
This publication has 22 references indexed in Scilit:
- Virilizing adrenocortical tumors in adult women. Report of 10 patients, 2 of whom each had a tumor secreting only testosteroneCancer, 1993
- VIRILIZING ADRENAL ADENOMA IN AN ADULT WITH THE BECKWITH-WIEDEMANN SYNDROME: PARADOXICAL RESPONSE TO DEXAMETHASONEClinical Endocrinology, 1989
- Testosterone-secreting adrenal adenoma in a peripubertal girlJAMA, 1987
- Virilization of two siblings by maternal androgen-secreting adrenal adenomaThe Journal of Pediatrics, 1986
- Sécrétion isolée de testostérone par une tumeur cortico-surrénale chez une femme ménopauséeLa Revue de Médecine Interne, 1986
- Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism.BMJ, 1986
- Clinical and laboratory findings and results of therapy in 58 patients with adrenocortical tumors admitted to a single medical center (1951 to 1978)The American Journal of Medicine, 1981
- ADRENOCORTICAL TUMOUR IN UNTREATED CONGENITAL ADRENOCORTICAL HYPERPLASIA ASSOCIATED WITH INADEQUATE ACTH SUPPRESSIBILITYClinical Endocrinology, 1981
- CUSHING'S SYNDROME, NODULAR ADRENAL HYPERPLASIA AND VIRILIZING CARCINOMAClinical Endocrinology, 1978
- ENDOCRINE STUDIES DURING STIMULATION-SUPPRESSION IN HIRSUTISMObstetrics & Gynecology, 1975